Kelley Kenneth J

Average Profitability
50.56%
Insider Buys Quantity
3
Insider Buys Sum
$1.01M
Insider Sells Quantity
22
Insider Sells Sum
$10.02M

Insider Activity of Kelley Kenneth J

The largest purchase of all time was on 2020-03-19 and amounted to 52629 shares of Halozyme Therapeutics, Inc. for $748,697.

The largest sale of all time was on 2020-12-07 and amounted to 35086 shares of Halozyme Therapeutics, Inc. for $1.44M.

Biography of Kelley Kenneth J

No biography is available at this moment.

2021-04-14SaleHalozyme Therapeutics, Inc.
HALO
director
5,000
0.0034%
$45.00$225,000-12.56%
2021-03-01SaleHalozyme Therapeutics, Inc.
HALO
director
5,000
0.0035%
$45.34$226,717-12.42%
2021-02-01SaleHalozyme Therapeutics, Inc.
HALO
director
5,000
0.0037%
$48.12$240,594-13.34%
2021-01-04SaleHalozyme Therapeutics, Inc.
HALO
director
5,000
0.0037%
$42.91$214,556-1.13%
2020-12-07SaleHalozyme Therapeutics, Inc.
HALO
director
35,086
0.0261%
$41.00$1.44M+4.06%
2020-12-02SaleHalozyme Therapeutics, Inc.
HALO
director
31,792
0.0235%
$41.00$1.3M+3.49%
2020-11-27SaleHalozyme Therapeutics, Inc.
HALO
director
10,000
0.0075%
$41.25$412,500+4.62%
2020-11-25SaleHalozyme Therapeutics, Inc.
HALO
director
9,671
0.0072%
$41.50$401,350+2.31%
2020-03-19PurchaseHalozyme Therapeutics, Inc.
HALO
director
52,629
0.0366%
$14.23$748,697+90.5%
2015-06-18SaleHalozyme Therapeutics, Inc.
HALO
director
20,000
0.0156%
$21.00$420,000-32.87%
2015-03-05SaleHalozyme Therapeutics, Inc.
HALO
director
40,000
0.0318%
$15.33$613,380+6.24%
2012-08-27PurchaseHalozyme Therapeutics, Inc.
HALO
director
20,000
0.0178%
$5.70$113,974+10.61%
2012-05-14PurchaseHalozyme Therapeutics, Inc.
HALO
director
20,000
0.0184%
$7.49$149,800-15.59%
2007-05-25SaleHalozyme Therapeutics, Inc.
HALO
director
45,000
0.0614%
$10.26$461,783-24.05%
2007-05-18SaleHalozyme Therapeutics, Inc.
HALO
director
30,000
0.041%
$10.55$316,586-24%
2007-05-07SaleHalozyme Therapeutics, Inc.
HALO
director
25,000
0.0349%
$10.40$260,089-19.06%
2007-04-30SaleHalozyme Therapeutics, Inc.
HALO
director
50,000
0.0695%
$10.33$516,392-17.83%
2007-04-23SaleHalozyme Therapeutics, Inc.
HALO
director
50,000
0.0675%
$8.85$442,385-5.25%
2007-04-16SaleHalozyme Therapeutics, Inc.
HALO
director
50,000
0.0686%
$9.07$453,444-5.65%
2007-04-09SaleHalozyme Therapeutics, Inc.
HALO
director
50,000
0.0691%
$8.46$423,106+2.63%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.